Objectives: Our paper measures the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in patients at the University Hospital of Frankfurt/Main, and correlates the prevalence with risk factors for exposure to and infection of healthcare workers (HCWs). Individual risk assessments were calculated for exposed HCWs.
INTRODUCTION
The problem of viral hepatitis and human immunodeficiency virus (HIV) in hospital populations around the world has been exhaustively studied, especially because of the fact that hospitalized patients overall, and in particular certain high-risk patients, represent a possible source of infection for healthcare workers (HCWs) . Epidemiological studies on the prevalence of infectious diseases have already been published, covering isolated groups of high-risk patients (Kelen et al., 1992; Montecalvo et al., 1995; Weber et al., 1995; Koulentaki et al., 2001) , HCWs (Cooper et al., 1992; Fisker et al., 2004; Wicker et al., 2007) as well as the general German population (Thierfelder et al., 2001) .
It remains a challenge in term of counseling individual caregivers with respect to their own personal risk of infection, e.g. after a needlestick injury (NSI). This information, in turn, might drive their difficult decisions (e.g. whether or not to take antiretrovirals, whether or not to breast-feed for recent or soon to be lactating mothers and a host of other life decisions) (Aiken et al., 1997; Beltrami et al., 2000; Dement et al., 2004; Panlilio et al., 2004; Lee et al., 2005; Gershon et al., 2008 Gershon et al., , 2004 Gershon et al., , 1995 .
Germany has a low prevalence of blood-borne infections. The prevalence of antibodies to hepatitis core antigen (anti-HBc) among the German population is $5 to 8%; the prevalence of HBs antigen (HBsAg) is $0.4 to 0.8%. The prevalence of hepatitis C virus (HCV) in the general population in Germany has been estimated at at least 0.4-0.7%, with nearly 400 000-500 000 virus carriersboth for hepatitis B virus (HBV) and HCV. The prevalence of antibodies to HIV among the German population is $0.05%; with about 56 000 people infected with HIV (RKI, 2008) .
HCWs are at risk for blood-borne infections, like HIV and viral hepatitis, and can also act as focal points in their onward transmission. In the last decades in Germany, only a small number of transmission of blood-borne viruses from HCWs to patients was reported (three HCWs who infected 63 patients with HBV and five HCWs who infected 11 patients with HCV) (Roß and Roggendorf, 2007) .
A vaccination is one of the best methods of protection against blood-borne infections. Vaccinations, however, are currently only available for HBV.
Occupational exposure to blood-borne pathogens can result from NSI, mucocutaneous contact or blood contact with non-intact skin. In Germany, $500 000 NSIs occur among HCWs each year (Hofmann et al., 2002) . This exposure can lead to infections with HBV, HCV and HIV and other blood-borne pathogens, e.g. cytomegalovirus, herpes simplex virus and parvovirus B19.
The risk of transmission of hepatitis B infection by an NSI is up to 30% for susceptible HCWs without post-exposure prophylaxis (PEP) or sufficient hepatitis B vaccination (Hofmann et al., 2002; Deisenhammer et al., 2006) . The risk of a HCV infection is estimated at between 3 and 10%, it increases .10-fold if the source patient has high levels of virus load (Trim and Elliot 2003; Hanrahan and Reutter 1997, Yazdanpanah et al., 2005) . A lower risk of infection is found for HIV, at ,0.3% (Cardo et al., 1997) .
In other parts of the world, the risk factors for transmission (e.g. use of safety needles, pre-vaccination, rapid and appropriate post-exposure follow up, etc.) of blood-borne viruses among HCWs are much higher. Each year, $66 000 HBV, 16 000 HCV and 1000 HIV infections were estimated to occur among HCWs worldwide due to their occupational exposure to percutaneous injuries (Prüss-Ü stün et al., 2005) .
We recently completed a separate study on the incidence of NSI in HCWs at the University Hospital at Frankfurt/Main (Germany) (Wicker et al., 2008) . In this paper, we extended our research to cover the prevalence of virus carriers (HIV/HBV/HCV) among patients in different departments of the University Hospital who gave blood for laboratory tests. The aim was to determine individual risk of infection, given an exposure with the parameters provided by patient prevalence and the protective factors. We thereby calculated the statistical probability of blood-borne virus infection of HCWs in the classical fields of medicine and surgery and underlined the importance of sufficient preventive measures.
METHODS

Population
The study took place in Frankfurt/Main, Germany. The Johann Wolfgang Goethe University Hospital has 1247 beds, 4080 employees and 12 medical disciplines. There are $44 000 in-patient admissions (2006) and $200 000 outpatients.
We analyzed retrospectively the results of virological examinations for HBV, HCV and HIV carried out on blood samples from patients admitted between March 2005 and March 2007.
Data were obtained from blood samples of patients in dermatology, the ear, nose and throat department, gynecology, internal medicine, neurology/psychiatry, ophthalmology, pediatrics' and surgery. In pediatrics, only children .12 months in age were included in the study to avoid the inclusion of maternal antibodies. Blood samples were collected either as a universal testing of all patients (in some parts of surgery) or when ordered by healthcare providers. There were no patient identifiers in the frame of this study because data analysis was done using a statistical program (Viro, Braun, Stockach, Germany) which attributed patient data to the above-mentioned medical disciplines.
A total of 13 358 blood samples from patients were tested for HBsAg. Anti-HCV was tested in 20 163 blood samples and anti-HIV in 13 381 blood samples. In each discipline, and for each parameter, at least 100 blood samples (range 102-5567) were tested.
Data on NSI were obtained in a previous study in 2006-2007 via an anonymous questionnaire covering occupational blood exposure among HCWs in a German University Hospital in the last 12 months (Wicker et al., 2008) . Overall, 1342 HCWs from the same eight disciplines as mentioned above took part in the study.
Definition of HCW and NSI
A HCW is defined as an employee in healthcare who comes into contact with patients or patients' body fluids. An NSI is defined as a laceration or puncture with a needle or other sharp instrument contaminated with blood or other bloody body fluids.
Questionnaire on prevalence of NSI among HCWs
Employees of the University Hospital, Frankfurt, Germany, were asked to complete a survey if they held a job that involved direct contact with patients as well as contact with blood or body fluids or sharp . The questionnaire included a brief introduction concerning the potential risk of NSIs. It also covered the incidence, reporting rate, risk factors and exposure mechanisms of NSIs, the procedure and instrument involved in the exposure, the circumstances and mechanisms that were thought to be a significant cause of the exposure, the professional group and, finally, the HBV vaccination status.
If the respondents had any further questions, they could contact the responsible occupational physician. This also applied if they had any other problems, e.g. sustained NSIs or questions about vaccination status and blood-borne infections. The completed questionnaires were collected on the various wards by the occupational physician or returned anonymously via internal mail. Feedback was not compulsory and informed consent was obtained by the participating personnel.
Serological testing
Sera were tested at the Institute of Medical Virology at the Johann Wolfgang Goethe University in Frankfurt/Main. Hepatitis B parameters were analyzed using AxSYM MEIA assays according to the manufacturer's instructions (Abbott, WiesbadenDelkenheim, Germany) (HBsAg-AxSYM HBsAg). Hepatitis C-specific antibodies were tested using an automated EIA system (Vitros ECI, Ortho Clinical Diagnostics, Neckargemünd, Germany). Reactive samples were confirmed in the Line Immunoblot Assay (INNOLIAä Score, Innogenetics, Bayer Corporation, Wuppertal, Germany). Anti-HIV was screened with the AxSYM HIV 1/2 gO MEIA assay (Abbott) and HIV 1/2 assay Vitros ECI automatic (Ortho Clinical Diagnostics). Reactive samples were confirmed in a western blot assay (New Lav Blot I and II, Bio-Rad Laboratories, Munich, Germany).
Risk assessment and statistical analysis
To calculate the nominal risk assessment of occupational exposure (NRE) to blood-borne viruses, the prevalences of HBsAg, anti-HCV and anti-HIV among the patients in the different medical disciplines were multiplied with the prevalence of NSI among HCWs in the corresponding medical disciplines. The formulas used (with specific data for each medical discipline) are NRE for HBV 5 HBsAg prevalence Â prevalence of NSI Â 1=100, NRE for HCV 5 anti-HCV prevalence Â prevalence of NSI Â 1=100, NRE for HIV 5 anti-HIV prevalence Â prevalence of NSI Â 1=100:
For the calculation of the nominal risk of infection (NRI), the HBV-, HCV-, and HIV-specific rate of infection per contaminated NSI was taken into account. This was considered to be 30% for HBV, 3% for HCV and 0.3% for HIV (Cardo et al., 1997) . The virus-specific rate was used as multiplier. Excluded from these calculations were the influence of a sufficient HBV vaccination and the effectiveness of a HIV-PEP. Furthermore, our calculations were made under the premise of independent transmission risks. This is, of course, not always accurate because double and triple infections of one patient might occur and so there might be a risk of transmission of HIV, HBV and HCV via a single NSI. The summation of the three virus-specific risk factors was named as 'maximal cumulative risk of infection (HBV, HCV and HIV) (MCRI)'. The formulas used (with specific data for each medical discipline) are For the nominal individual risk assessment for an infection (NIRI) with HBV, HCV and/or HIV, we took into consideration whether a HCW had had a sufficient HBV vaccination and if he or she had had access to HIV-PEP. If a sufficient HBV vaccination existed, the HBV transmission risk was calculated to be zero. Antiretroviral therapy (HIV-PEP) administered within 24-36 h after NSI is associated with an 81% reduction in HIV infection (Cardo et We calculated the theoretical risk of acquiring an (HBV, HCV and HIV) infection via a single NSI. The calculation was done by dividing 100 by the ward-specific NIRI value.
For the statistical analysis 95% confidence intervals (CIs) for proportions were calculated using the program BiAS für Windows 8.3 (Epsilon Verlag, Hochheim, Darmstadt, Germany, 2007) .
Ethical considerations
The seroprevalence data were collected by retrospective analysis of computer data from the Institute for Medical Virology. The NSI data were collected from a voluntary questionnaire completed by HCWs. Only personnel who gave informed consent participated. However, we can confirm that participants cannot be identified from the material presented and that no plausible harms to participating individuals arise from the study.
RESULTS
The study included 13 358 patients tested for HBsAg, 20 163 patients tested for anti-HCV and 13 381 patients tested for anti-HIV.
The prevalence of HBsAg was 5.3% (n 5 709/ 13 358), for anti-HCV 5.8% (n 5 1167/20 163) and for anti-HIV 4.1% (n 5 552/13 381).
The prevalence of HBV carriers ranged from 0.95% (95% CI 0.7-1.3) in surgery to 11.35% (95% CI 10.5-12.3) in internal medicine. The prevalence of HIV and HCV seropositive were lowest in surgery (0.34%, 95% CI 0.2-0.6) and ear-nosethroat medicine (1.08%, 95% CI 0.7-1.6). The highest prevalence of HCV and HIV carriers was found in the department of internal medicine (14.62%, 95% CI 13.7-15.6 and 15.4%, 95% CI 14.2-16.9). Prevalence rates of HBsAg, anti-HCV and anti-HIV carriers among the patients of the different medical disciplines are summarized in Table 1 .
In a previous study at the University Hospital in Frankfurt, the number of NSI among HCWs was recorded over a 12-month period in 2006-2007. The number of reported NSI was re-evaluated in this study and varied widely across the eight disciplines involved, ranging from 46.9% in medical staff in surgery to 18.7% in pediatrics. Overall, 32.3% (95% CI 29.8-34.9) of respondent HCWs had sustained at least one NSI. Table 2 shows the observed rates of NSI among the different medical disciplines as previously described (Wicker et al., 2008) .
The risk of NSI-related viral transmission for HCWs in the different medical disciplines depended on the frequency of NSI and the prevalence of infectious patients. 
blood-borne infections (HBV, HCV and HIV) among
HCWs in the different medical disciplines. In addition to these risk assessments, the risk of an infection with HBV, HCVor HIV via an NSI varies for each blood-borne virus and is estimated to be at 30% for HBV, 3% for HCVand 0.3% for HIV. The summation of the risks of transmission of HBV, HCV and HIV showed that the nominal highest risk of acquiring a blood-borne infection via NSI was for HCWs in the field of internal medicine. A lower risk was found for HCWs in ophthalmology and pediatrics, while the nominal lowest risk was in dermatology, surgery, ear-nose-throat medicine, gynecology and neurology/psychiatry (see Table 4 ). Therein it is not taken into account that the exposure time, depth of injury and amount of transmitted blood volume are important factors for the risk of virus transmission.
The nominal individual risk assessment for an infection (Fig. 1) took into account in which department the HCW was working, if he or she had had a sufficient HBV vaccination and if he or she had had access to HIV-PEP.
DISCUSSION
Around 350 million people suffer from chronic HBV infection worldwide, $125 million people are infected with HCV and $33 million with HIV, making viral hepatitis and HIV two of the world's greatest infectious diseases (Russmann et al., 2007) . The rising number of people carrying blood-borne pathogens in the population consequently poses a significant occupational health hazard to HCWs (Weiss et al., 2005) . The high frequency of NSI among HCWs should increase the focus on prevention. Despite mandatory classes on exposure and universal precautions, a previous study among professionals at the University of Frankfurt found an under-report rate of 75% (Wicker et al., 2008) . However, the prompt reporting of NSI is important, not only for management of the exposure but also for identification of workplace hazards and evaluation of preventive measures (Beltrami et al., 2000) . The true number of NSIs sustained by HCWs is still unclear, primarily due to under-reporting and the issue of HCWs seeking care outside of the workplace for a host of reasons.
Several studies have quantified this blood-borne pathogen risk, with some focusing on the frequency of NSI and others concentrating on virus prevalence among patients. However, no study has as yet compiled a correlation of the frequency of NSI among HCWs and the prevalence of virus carriers among patients treated in different medical fields.
The current study presents data on the prevalence of blood-borne viruses in patients, as well as risk factors for transmission among HCWs in a German University Hospital. The prevalence of HBV, HCV and HIV among patients who were tested for these infections of the University Hospital Frankfurt/ Main was 5.3% (ranging from 0.95 to 11.35% in the different disciplines), 5.8% (ranging from 1.08 to 14.62%) and 4.1% (ranging from 0.34 to 15.4%), respectively. Our results indicate that the overall prevalence in patients with blood-borne infection was about nine times higher for HBV, $15 times higher for HCV and $82 times higher for HIV, compared with the general German population (Table 1) .
Similar data were published in several other studies, which showed that the prevalence among patients in the different hospitals and countries was always higher than in the general population (Kelen et al., 1992; Neto et al., 1995; Vladutiu et al., 2000; Koulentaki et al., 2001; Houston et al., 2004; López et al., 2005; Xeroulis et al., 2005; Russmann et al., 2007; Sit et al., 2007) . Thus, given a higher likelihood that an infected individual will require medical treatment, it may be inaccurate to base estimates of blood-borne pathogen incidence on the known estimates in the general population. The transmission of blood-borne pathogens between patients and HCWs is related to the frequency of exposures that could potentially lead to transmission, the prevalence of disease in the source population, the risk of transmission given an exposure to an infected source (viral load, the depth of the injury and amount of transmitted blood) and the effectiveness of vaccines and PEP (Cardo et al., 1997; Hofmann et al., 2002; Xeroulis et al., 2005) .
An important tool to protect HCWs against occupational blood-borne viral infection is universal precautions (e.g. gloves, gowns and facial protection), HBV vaccination and the use of safety devices. These devices are a suitable and important tool in the reduction of NSIs, and the implementation of safety devices should result in an improvement in medical staff's health and safety (Sohn et al., 2004; Tuma and Sepkowitz 2006; Wicker et al., 2008) . The use of safety devices is considerably lower in Germany than in US. This may be the reason for the higher injury rate in Germany [500 000 NSIs among 750 000 HCWs (Hofmann et al., 2002) ] versus 100 000 to 1 million NSIs among 6 million HCWs in US (Panlilio et al., 2004; Sepkowitz and Eisenberg, 2005) .
Previous data have shown that exposure to bloodborne pathogens is an occupational risk for HCWs, with surgeons having the highest rate of NSI compared with other specialists (Wicker et al., 2008 US multicenter study on the frequency of NSI among surgeons in training, showing that the frequency of NSI is much higher than commonly assumed. By their final year of training, 99% of residents had had an NSI (Makary et al., 2007) . Summarizing the data of multiple studies (Alter, 2005; Weiss et al., 2007) , HCWs have a higher risk of occupational infections with blood-borne viruses in comparison to non-medical employees. But this risk varies widely, depending on the frequency and kind of contacts with potentially contaminated patient material. We therefore calculated a nominal individual risk of exposure (Table 3) , comprising the most important risk factors, such as frequency of NSI ( Table 2 ) and prevalence of infectious patients (Table 1) . Nevertheless, the potential variability of degree of exposure (i.e. seriousness or severity of exposure, quantity of transmitted blood or contaminated material) was not taken into account. This might vary in the different disciplines, e.g. between internal medicine and surgery. Furthermore, because of lack of data, it was not clear whether multiple needlestick occurrences involved the same patient.
In this study, the nominal highest risk of needlestick-related viral infection (Table 4) was carried by HCWs in the field of internal medicine because of the higher prevalence of blood-borne pathogens in their patients, as well as a high rate of NSI.
The data in Fig. 1 show that without PEP or vaccination, theoretically each 64th NSI among HCWs in the department of internal medicine leads to an infection of one or more of the three major blood-borne viruses (HBV, HCV and HIV) . Under the premise of a sufficient HBV vaccination and an 81% fall in the risk of HIV transmission when using a PEP after an NSI (Bassett et al., 2004) , the cumulative theoretical risk for the HCW of contracting HCV or HIV via an NSI drops to each 544th NSI in the department of internal medicine (see Fig. 1 ). This means that the individual risk for an NSI-related infection of HCWs mainly depends on preventive factors such as HBV vaccination and HIV-PEP. The data show that the HBV vaccination has the highest potential to reduce the individual risk of infection by NSI. Besides this, it should be stressed that an important tool to protect HCWs against occupational blood-borne viral infection are universal precautions (e.g. gloves, gowns and facial protection), HBV vaccination and the use of safety devices.
This study has some limitations: First, we covered only a proportion of our patients. A high ratio of the samples were ordered by healthcare providers, which could result in the fact that the prevalence of infection is much higher in this group of patients compared with all hospital patients, this may have unwillingly resulted in selection bias and led to an overestimation of the true seroprevalence rates. Second, data cannot be generalized to cover all German hospitals. Frankfurt/Main is a metropolis city and has one of the highest incidence rates of HBV, HCV and HIV in Germany.
Furthermore, it should be stressed that the transmission of blood-borne viruses is often not an independent risk because double and triple infections of one patient might occur and so the risk of transmitting HIV, HBV and HCV via a single NSI might be possible.
HCWs-especially in an urban university environment-face significant occupational risks through their exposure to HIV, HBV or HCV. A universal strategy for occupational safety is therefore required. Our results underline the importance of the consistent implementation of preventive measurements, such as HBV vaccinations and HIV-PEP, and for the increased use of safety devices to prevent occupational exposures in the healthcare environment. These devices are a suitable and important tool in the reduction of NSI, and their use should result in an improvement in medical staff's health and safety (Clarke et al., 2002; Cullen et al., 2006; Wicker et al., 2008) . Universal precautions are a vital part of any comprehensive occupational safety program and should be as sophisticated as possible.
CONCLUSIONS
(i) Our study offers an opportunity to calculate the nominal (individual) risk for exposure of and infection with blood-borne viruses after NSI in a hospital setting. (ii) The prevalence of blood-borne infection in hospital patients is higher than in the general population. (iii) Our study underlines the importance of HBV vaccinations and access to HIV-PEP for HCWs and the use of safety devices as the most important measures to prevent blood-borne infections of HCWs after NSI.
